Clinical Trial Update: Pharmacokinetics and Metabolism of Radiolabeled BMS-690514 in Healthy Male Subjects [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetics and metabolism study of radiolabeled BMS-690514 in healthy male volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• BMS-690514

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Cancer | Phase 1 | Status: COMPLETED